U-Neuron Biomedical

U-Neuron Biomedical P/CF

The P/CF (Price-to-Cash-Flow Ratio) of U-Neuron Biomedical (6973.TWO) as of Oct 19, 2026 is -28.53. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was -28.92 — a change of -1.32% (higher).

P/CF

-28.53

YoY

-1.32%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of U-Neuron Biomedical is 2024 -28.53 . P/CF (Price-to-Cash-Flow Ratio) of U-Neuron Biomedical was 2023 -28.92 . It decreases by -1.32% higher compared to the previous year.

The U-Neuron Biomedical P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2021
-2,356.04 TWD
Jan 1, 2022
-42.32 TWD
Jan 1, 2023
-28.92 TWD
Jan 1, 2024
-28.53 TWD
The U-Neuron Biomedical P/CF history
YEARP/CFYoY
-28.53-1.32%
-28.92-31.68%
-42.32-98.20%
-2,356.04—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

U-Neuron Biomedical Stock analysis

What does U-Neuron Biomedical do? U-Neuron Biomedical Inc, headquartered in Taipei, Taiwan, operates in the Health Care sector within the Biotechnology industry. The company, listed on 20 July 2023, develops cosmetics, health care consumer products, and new drugs. Its drug development focuses on allogeneic amniotic fluid stem cells for applications like erectile dysfunction (UA002) and dry eye (UB003). Cosmetic products, featuring deer amniotic fluid stem cell derivatives, include anti-aging masks, essences, and creams for repair and hydration, primarily sold domestically in Taiwan. U-Neuron Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about U-Neuron Biomedical stock

P/CF (Price-to-Cash-Flow Ratio) of U-Neuron Biomedical is -28.53 in 2024.

P/CF (Price-to-Cash-Flow Ratio) of U-Neuron Biomedical changed from -28.92 to -28.53, representing a -1.32% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) U-Neuron Biomedical since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s U-Neuron Biomedical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — U-Neuron Biomedical

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — U-Neuron Biomedical